This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jan 14;379(9811):e10; author reply e10-11.

doi: 10.1016/S0140-6736(12)60063-4.

Exon-skipping therapy for Duchenne muscular dystrophy

Satyakam Bhagavati

PMID: 22243826
DOI: 10.1016/S0140-6736(12)60063-4

Comment

Exon-skipping therapy for Duchenne muscular dystrophy

Satyakam Bhagavati. Lancet. 2012.

. 2012 Jan 14;379(9811):e10; author reply e10-11.

doi: 10.1016/S0140-6736(12)60063-4.

Author

Satyakam Bhagavati

PMID: 22243826
DOI: 10.1016/S0140-6736(12)60063-4

No abstract available

PubMed Disclaimer

Comment on

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, Garralda ME, Bourke J, Wells DJ, Dickson G, Wood MJ, Wilton SD, Straub V, Kole R, Shrewsbury SB, Sewry C, Morgan JE, Bushby K, Muntoni F. Cirak S, et al. Lancet. 2011 Aug 13;378(9791):595-605. doi: 10.1016/S0140-6736(11)60756-3. Epub 2011 Jul 23. Lancet. 2011. PMID: 21784508 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database